Driver FixRecommendedSound, Wi-Fi or graphics acting up? Check drivers firstFind missing or outdated drivers fast.Check DriversThanksgiving DealsAmazon USThanksgiving week: Black Friday picks start earlyAmazon US: current deals, useful picks and tech finds.Check DealsWindows FixRecommendedWindows errors stealing your time? Find the fix fastScan stability, cleanup and performance issues.Fix Now×
Skip to the story
DocumentaryTubeTRUE STORIES, ON SCREEN.
  1. DocumentaryTube
  2. The Screening Room
  3. Blog

Blog

How to Read FDA Clearance and CLIA Certification for Diagnostic Tests

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Some links on this page are affiliate links: if you buy through them we may earn a commission, at no extra cost to you.

FDA status and CLIA status answer different questions. FDA clearance, approval, authorization, or licensure applies to a diagnostic test system and the exact intended use in its labeling. CLIA certification applies to the laboratory or testing site and the conditions under which it performs testing on human specimens. A reliable evaluation checks both independently: first determine what FDA action covers the test and its intended use, then confirm that the laboratory has the right CLIA certificate and complexity coverage for the work it performs.

What each credential actually tells you

FDA status belongs to the test system

When the Centers for Disease Control and Prevention describes a test as FDA-cleared, it means FDA reviewed the test system and found it substantially equivalent to a legally marketed test for the same use. That finding is tied to a defined intended use, not to every possible use of the instrument or kit.

The labeling should identify what the system detects or measures, which specimen types may be used, the patient population, the setting, the instrument or analyzer, and important limitations. A test can be cleared for one specimen or population and not for another. A laboratory or advertisement that leaves out those boundaries is giving you less information than the FDA record provides.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

CLIA status belongs to the laboratory

The Clinical Laboratory Improvement Amendments (CLIA) program governs facilities that test human specimens to assess health or diagnose, prevent, or treat disease. CMS states that a facility performing this kind of testing generally needs an appropriate CLIA certificate. The certificate concerns the facility’s personnel, procedures, quality systems, records, and other operating requirements for the testing it performs.

A CLIA certificate is therefore not an FDA marketing decision. It does not show that every assay offered by the laboratory is FDA-cleared, FDA-approved, authorized, or licensed. Conversely, FDA clearance of a test system does not certify that a particular laboratory is competent, inspected, or authorized to perform it.

Three federal agencies, separate responsibilities

CMS, FDA, and CDC have distinct roles in CLIA administration. FDA evaluates and categorizes test systems within its authorities; CMS administers the CLIA certification and oversight program; CDC provides technical and program resources. Treating any one agency’s action as a substitute for another’s is the source of many misleading claims.

Question Credential or record to examine What it does not establish
Was this test system reviewed for a defined use? FDA record and current labeling That a particular laboratory operates correctly
Can this site perform human-specimen testing under CLIA? Laboratory’s CLIA certificate and scope That every assay is FDA-marketed or clinically valid
How demanding are the laboratory requirements? Test-specific CLIA complexity category That the test’s location makes it waived
Does the method match the patient’s situation? Intended-use section, limitations, and laboratory method That a similar-sounding test has the same authorization

Do not collapse FDA’s regulatory verbs

Cleared

Clearance generally refers to FDA’s finding that a test system is substantially equivalent to a legally marketed predicate for the same intended use. Read the specific intended-use language rather than treating “FDA-cleared” as a general endorsement of all results or all clinical decisions.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Approved

Approval is a different FDA pathway with its own evidence and legal standard. An approved test may not have the same labeling, population, specimen, or setting as a cleared test. Confirm the action recorded by FDA instead of replacing every regulatory term with “approved.”

Authorized

Authorization is another pathway, often used for a defined situation or period. Its conditions and limitations are set out in the authorization and accompanying instructions. Do not assume that authorization has the same scope or permanence as clearance or approval.

Licensed

Licensure is a separate FDA term used for certain products and regulatory routes. The word alone does not tell you the permitted specimen, population, instrument, or setting. The controlling information is the current FDA record and package insert.

For any of these verbs, look up the exact action and then read the current labeling. A product page, sales sheet, or laboratory webpage may use a shorter phrase than the official record and can omit restrictions that matter to a patient’s result.

Free tools Windows power users keep installed

One-click scans. No signup required.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Read intended use before reading performance numbers

Match the analyte and specimen

Start with what the test detects or measures and the specimen it accepts. Blood, saliva, swab, tissue, and other specimen types are not interchangeable merely because they are used with the same disease name. If the specimen collected from a patient is outside the labeled type, performance figures from the label may not apply.

Match the population and setting

Check whether the intended use covers the patient’s age group, symptoms, screening or diagnostic purpose, and care setting. A test labeled for symptomatic people may not be established for asymptomatic screening. A system intended for professional use may have different instructions from one categorized for waived use.

Match the instrument and workflow

Some authorizations cover a specific analyzer, software version, cartridge, or collection device. Substituting a component, changing preparation steps, or moving the method to another instrument can create a modified procedure rather than the labeled system.

Read limitations and controls

Limitations explain when a negative, positive, or indeterminate result needs confirmation or clinical context. Required controls, storage conditions, timing, and invalid-result procedures are part of the test’s approved or cleared use. Performance percentages have meaning only under those conditions.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Understand CLIA complexity and why point of care is not a waiver

Waived testing

Waived tests are considered simple to perform and carry a low risk of an incorrect result when used as directed. Waiver is assigned to the specific test system, not to a room, clinic, pharmacy, ambulance, or other location. A site may perform a waived system under a certificate appropriate for waived testing, but that does not make every test at that site waived.

Moderate- and high-complexity testing

Nonwaived testing is categorized as moderate or high complexity. These categories bring more demanding requirements for qualified personnel, written procedures, quality control, proficiency testing, records, and inspection. A laboratory’s certificate and scope must cover the complexity and specialties of the testing it performs.

Point-of-care testing

Point of care describes where testing occurs—at the bedside or near the site of patient care. It says nothing by itself about complexity. A near-patient molecular or other instrument can be moderate or high complexity, while a different system at the same location may be waived. Always check the test’s actual CLIA categorization and the manufacturer’s instructions.

What a CLIA certificate proves

The certificate shows that the facility is operating under the CLIA framework applicable to its testing. To evaluate it, confirm the certificate type, current validity, and specialty or subspecialty coverage for the assays being performed. A certificate is not a blanket license for unrelated methods, and it is not a statement that a test has FDA clearance or established clinical validity.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

A practical reading sequence

  1. Identify the exact regulatory verb. Record whether FDA calls the system cleared, approved, authorized, or licensed. Ask for the FDA record and current package insert if a webpage uses only the phrase “FDA approved.”
  2. Write down the intended use. Capture the analyte, specimen, population, setting, instrument, and purpose. Treat any mismatch as a separate question rather than assuming the result transfers.
  3. Locate the performance and limitation sections. Read how the manufacturer established performance, what controls are required, and what situations can produce invalid or misleading results.
  4. Check the CLIA category. Use FDA’s CLIA categorization resources and the manufacturer’s instructions to determine whether the exact system is waived, moderate complexity, or high complexity. Do not infer the category from a point-of-care location.
  5. Verify the performing laboratory. Ask for the site’s CLIA certificate information and confirm that its certificate and specialty or subspecialty coverage match the method. A laboratory may have a certificate while a particular test falls outside its covered scope.
  6. Ask whether the method was changed. Find out whether the laboratory altered specimen preparation, reagents, instruments, software, reporting thresholds, or other components, or developed the method in-house.
  7. Apply the stricter interpretation when details conflict. If a marketing statement is broader than the FDA label, follow the label. If a laboratory’s certificate does not clearly cover the method, request clarification before relying on the result.
  8. Separate laboratory operation from clinical meaning. CLIA oversight addresses accurate and reliable laboratory operation. It does not, by itself, determine whether a test result is clinically valid for a particular diagnosis or treatment decision.

How to check whether a test is FDA-cleared or otherwise authorized

Search the official record

Use FDA’s device record or other applicable FDA database, searching the test name, manufacturer, model, or identifying number shown in the package insert. Confirm that the record corresponds to the exact system in use, not merely a product family with a similar name.

Open the current labeling

Read the intended-use statement, specimen requirements, patient population, setting, instrument, controls, and limitations. Check revision dates and any notices that supersede an older insert. A laboratory’s test menu should be consistent with this labeling unless it clearly identifies a validated modification or laboratory-developed method.

Confirm the action and its scope

Note the FDA action—clearance, approval, authorization, or licensure—and the scope attached to it. “FDA-cleared” is not a synonym for “FDA-approved,” and none of these words means that every use has been evaluated.

How to check a laboratory’s CLIA certification

Request the basic certificate details

Ask the testing site for its CLIA certificate type, certificate number, expiration or current status, and the specialties or subspecialties covered. A reputable laboratory should be able to identify the certificate under which the test is performed.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Match the certificate to the method

Compare the certificate’s scope with the test’s complexity and discipline. A site that performs nonwaived testing needs the corresponding personnel qualifications, quality-control program, proficiency testing where required, records, and inspection status. A waived certificate does not authorize moderate- or high-complexity procedures.

Investigate contract and referral arrangements

The organization collecting a specimen may not be the laboratory performing the assay. Identify the actual testing site and verify that site’s certificate. A clinic’s credentials cannot substitute for the certificate of an external laboratory that runs the specimen.

Modified tests and laboratory-developed tests require extra caution

Why a modification changes the analysis

Changing a cleared or approved system can move the procedure outside the manufacturer’s intended use. Examples include using a different specimen type, combining components from different systems, altering extraction or amplification steps, changing software or reporting thresholds, or transferring the method to another instrument. The original FDA status does not automatically cover the modified procedure.

Laboratory-developed tests

CDC guidance treats laboratory-developed tests and modified tests as high complexity by default. Before reporting patient results, CLIA requires the laboratory to establish specified performance characteristics for the method it actually performs. The laboratory must be able to support its claims for accuracy and reliability under its own conditions, not simply cite a component’s prior clearance.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Ask what was validated

For an in-house or modified method, ask which specimen types, populations, instruments, controls, and reporting rules were validated. Also ask how the laboratory handles changes, quality control, proficiency testing, invalid results, and corrective action. These questions address the method in use rather than a predecessor product.

Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Support on Ko-Fi

Analytical performance is not clinical validity

Analytical performance concerns whether the laboratory method measures or detects the target reliably under defined conditions. Clinical validity concerns how well that result represents a disease, condition, or clinical outcome in the intended population. CLIA oversight focuses on the quality and reliability of laboratory operations; the CLIA program does not itself decide a test’s clinical validity.

FDA labeling may provide evidence and limitations relevant to the test’s intended use, but a laboratory certificate alone cannot answer whether a result should guide a particular treatment. Interpret the result with the labeled population, specimen, setting, and clinical context in view.

How to compare two tests or two laboratories

Use the same questions for every option so that an attractive label or convenient location does not decide the comparison.

What’s actually slowing this PC down?

Pick the symptom - the matching free tool is one click away.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.
Comparison axis What to record Why it matters
Regulatory pathway Clearance, approval, authorization, licensure, or no FDA marketing submission identified Different pathways have different scopes and conditions
Intended-use match Analyte, specimen, population, setting, instrument, and stated purpose A result is meaningful only within the use evaluated or validated
CLIA category Waived, moderate complexity, or high complexity Category determines laboratory personnel, quality, proficiency, and inspection obligations
Laboratory credentials Certificate type, specialty coverage, inspection or accreditation status, and quality systems Confirms that the performing site is operating under the appropriate CLIA requirements
Evidence and limitations Label performance, required controls, known limitations, and confirmation rules Prevents broad claims from replacing the conditions behind the data
Method changes Any in-house development or modification of the labeled system Can create new validation and complexity obligations

Common mistakes and how to correct them

Mistake Why it is wrong Correction
Calling every FDA action “approved” Clearance, approval, authorization, and licensure are distinct pathways Use the exact term in the FDA record and read its conditions
Assuming a CLIA-certified laboratory uses only FDA-cleared tests CLIA certifies laboratory operations, not the marketing status of every assay Check each test’s FDA status separately
Assuming point-of-care means waived Point of care describes location, not complexity Verify the test-specific CLIA category
Using a clearance for a different specimen or population FDA scope is tied to intended use Match the label to the actual patient and specimen
Ignoring a laboratory modification A changed method may no longer be the labeled system Ask what was changed and what performance characteristics were established
Treating a certificate as proof of clinical validity CLIA oversight does not determine clinical validity Review FDA evidence, labeling, and clinical context separately
Checking only the collection site The collector may refer testing elsewhere Verify the certificate of the laboratory that performs the assay

Illustrative scenarios

A waived test at a clinic

A clinic performs a test near the examination room and displays a CLIA certificate. The correct reading is: identify the exact kit, confirm that FDA categorization lists that system as waived, read its specimen and patient-use limits, and verify that the clinic’s certificate covers waived testing. The location supports the description “point of care,” but it is not the reason the test is waived.

A molecular assay in a hospital laboratory

A hospital runs an instrument-based molecular assay and advertises rapid results. Check the FDA action and intended use, then verify whether FDA categorizes the system as moderate or high complexity. Confirm that the hospital’s CLIA certificate, personnel, quality-control program, proficiency testing, and inspection status cover that complexity. Speed and location do not reduce those requirements.

An in-house method based on a commercial kit

A laboratory changes extraction chemistry and reporting thresholds from a commercial system and calls the procedure its own assay. The original kit’s FDA status cannot simply be transferred to the modified method. Treat the procedure as a laboratory-developed or modified test, ask for the laboratory’s validation of specified performance characteristics, and apply the corresponding high-complexity expectations.

A concise checklist before relying on a result

  • Have you recorded the exact FDA action rather than using “approved” as a generic label?
  • Does the labeled intended use match the analyte, specimen, patient population, setting, and instrument?
  • Have you read the current limitations, controls, and invalid-result instructions?
  • Is the test’s CLIA category verified from a test-specific source?
  • Have you identified the laboratory that actually performed the assay?
  • Does that laboratory hold a current certificate with the appropriate specialty or subspecialty coverage?
  • Was the method modified or developed in-house, and if so, were its performance characteristics established before reporting results?
  • Are you keeping laboratory quality credentials separate from the question of clinical validity?

The dependable interpretation is a two-part check: FDA status defines what the test system was reviewed or authorized to do, while CLIA status defines whether the performing laboratory is operating under the requirements for its method. Neither credential replaces the other, and neither should be read more broadly than its documented scope.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply. Prices as of November 22, 2026 6:29 am GMT+0530.

About the author

— The DocumentaryTube Team writes The Screening Room's guides, reviews and news, and keeps the directory's records of documentaries, their directors and where to watch them. How DocumentaryTube works.

More in Blog

Say something about this film

Your email address will not be published. Required fields are marked *

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Recommended PC Tool
Recommended PC Tool
Windows Errors? Fix Them Before They SpreadFree repair scan
Crashes, No Sound, or Screen Glitches?Free driver scan

Two free Windows tools

One Free Minute Could Fix That PC

Before you go - each of these free tools takes about a minute and tackles what quietly slows a Windows PC down.

Special offer. View Outbyte info, uninstall instructions, EULA, and Privacy Policy.